Carlos Garner honored as COVID-19 hero
The College of Human Sciences held its annual International Quality of Life Awards (IQLA) virtually.
“We are proud to announce the 2020 IQLA honorees are the heroes of COVID-19,” explained Dean of the College of Human Sciences Susan Hubbard.
In its 27th year, Carlos Garner ’92 from the College of Sciences and Mathematics (COSAM) was a recipient. Honored by David Thrasher, Garner is a vice president of global regulatory affairs at Eli Lilly and Company in Indianapolis.
Since 1997, Garner has been working at Eli Lilly. He and the Lilly team have worked tirelessly from the beginning of the pandemic to discover and develop therapeutics to treat or prevent COVID-19. This effort has culminated in the emergency authorization of two drugs to treat patients with COVID-19.
He graduated with a bachelors’ degree in chemistry from Auburn University. He completed his graduate studies in chemistry and clinical pharmacology at Vanderbilt University.
Garner continues to give back to Auburn University. In September 2018, he spoke to students about the process for new pharmaceutical drugs including discovery and clinical development.
He serves on the board of directors for the Lilly PAC and is an active member of the COSAM Dean’s Leadership Council.
Garner represents Lilly at the Pharmaceutical Manufacturers of America and the National Academies of Sciences Forum on Drug Discovery, Development and Translation.